October 14, 2005 link to pdf of original letter Dr. Russell Katz Director, Neuropharmacological Drug Products Food and Drug Administration, FDA 120 1451 Rockville Pike, Room 4037 Rockville, MD 20852 Re: FDA Neurontin Safety Analyses Dear Dr. Katz: Due to the continued public danger facing a substantial class of…
Bush’s Choice for F.D.A. Chief to Keep Other Job Mon, 26 Sep 2005 President Bush proposes to appoint Dr. von Eschenbach to head the FDA while at the same time maintaining his “day job” as head of the National Cancer Institute. Clearly the administration thinks very little about the importance…
Medical Costs: “It’s a broken system. And at some point, it will fall apart" – Conflicts of Interest – NYT Thu, 22 Sep 2005 Medical device manufacturers have taken a leaf from pharmaceutical companies–they too bribe doctors to use their products. The New York Times repors about one such case…
EPA Exceptions to proposed Rules Allow Pesticides experiments on Children – Baltimore Sun Thu, 15 Sep 2005 “For the first time in our nation’s history, the EPA has proposed a program to allow for the systematic and everyday experimentation of pesticides on humans,” said Congressman Henry A. Waxman, a leading critic…
Abbott Seeks FDA approval for cancer drug despite failed trials – WSJ Mon, 12 Sep 2005 Abbott Laboratories is asking the FDA to approve a cancer drug even though it failed in clinical trials to demonstrate a benefit greater than placebo–which is a minimal FDA requirement. The Wall Street Journal…
FDA Had Report of Heart Device failures Mon, 12 Sep 2005 A series of irresponsible national policies put corporate interests above public safety undermining the health and lives of American citizens. The world witnessed the consequences of those irresponsible policies: namely, a colossal break down in the nation’s homeland security…
Testimony by Vera Hassner Sharav, President ALLIANCE FOR HUMAN RESEARCH PROTECTION (AHRP) www.ahrp.org Hearing of the NYS Assembly Committee on Health and Committee on Children and Families September 8, 2005 New York City I speak on behalf of the ALLIANCE FOR HUMAN RESEARCH PROTECTION (AHRP), the organization that filed the…
EPA Declines to Show Proposed Regulations for Human Pesticide Experiments Wed, 7 Sep 2005 When the committee of the Institute of Medicine gave the pesticide industry and the EPA the green light to accept data from human pesticide experiments, it opened the door for government-sanctioned experimental abuse that surpasses the…
Olive Oil Better than Anti-Inflammatory Drugs Tue, 6 Sep 2005 Amidst the disaster, one ray of good news for universal good health! This news was burried in a side bar of the Science section of The New York Times. Contact: Vera Hassner Sharav 212-595-8974 The New York Times September 6,…
Joint Commission on Accreditation of Healthcare Orgs & NCQA Fri, 9 Sep 2005 After much hand wringing following public disclosrure that the current IRB (institutional review board) research review and approval process is so inadequate and unreliable, the (then) outgoing Secretary of Health and Human Services, Donna Shalala, acknowledged in…
John H. Noble, Jr., Ph.D. John H. Noble, Jr., Ph.D., retired in August, 2005, from his position as Endowed Professor for Social Justice, The Catholic University of America. He has been Professor Emeritus since 1993 at the State University of New York at Buffalo, where he held joint appointments in…
Johnson & Johnson stung by its own Advisory Committee–Natrecor should be strictly limited Fri, 12 Aug 2005 Kudos go to Dr. Eugene Braunwald and the 10 members of the advisory committee that he heads. Contrary to Johnson & Johnson expectations, the committee recommended extensive warnings to physicians against prescribing Natrecor…
